Development and validation of a reflex test for myeloma diagnosis

  • Research type

    Research Study

  • Full title

    Investigating the use of routine blood tests and reflex testing to improve the early diagnosis of myeloma

  • IRAS ID

    288640

  • Contact name

    Richard Neal

  • Contact email

    R.D.Neal@leeds.ac.uk

  • Sponsor organisation

    University of Leeds

  • Duration of Study in the UK

    0 years, 11 months, 31 days

  • Research summary

    This project is aimed at improving the early diagnosis of myeloma. Myeloma is a type of blood cancer and accounts for approximately 2% of all newly diagnosed cancers in the UK each year. It mainly affects older people. Once myeloma is suspected, it is relatively easy to diagnose. However, suspecting myeloma is difficult for several reasons and as a result is one of the hardest cancers to diagnose. There are many reasons why myeloma is difficult to diagnose for GPs; it is a rare disease (an average full time GP will only see one new case every 8-9 years) and the main symptoms (including back pain, bone pain, tiredness and repeated infections) are vague and common to many non-cancer conditions that occur in the elderly. Diagnosing myeloma earlier is important as it allows patients to receive less toxic treatment, potentially reducing side effects and improving quality of life.

    Many myeloma patients receive numerous blood tests in the years before diagnosis, often for reasons unrelated to myeloma. In this study we propose to describe and compare results from routine blood tests conducted in myeloma and non-myeloma patients and develop an algorithm to identify people at highest risk of myeloma. Overall our study will determine if we can diagnose myeloma earlier using information from these routine blood tests. The advantage of this approach is that it removes one of the current most important stumbling blocks in myeloma diagnosis and this is that it bypasses the step that someone has to actively think about myeloma as a possibility. There is no additional burden for patients to collect blood, no further costs and time delays in obtaining bloods.

  • REC name

    Yorkshire & The Humber - Sheffield Research Ethics Committee

  • REC reference

    20/YH/0304

  • Date of REC Opinion

    10 Nov 2020

  • REC opinion

    Favourable Opinion